Clinical Trial Update: A Study to Evaluate the Safety and Drug Levels of ASP5541 in Chinese Participants With Prostate Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial to evaluate the safety and drug levels of ASP5541 in Chinese participants with prostate cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Hormone-sensitive Prostate Cancer
• Prostate Cancer

Drugs mentioned

• ASP5541

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer | Phase 1 | Status: RECRUITING